Anne Klibanski
👤 PersonAppearances Over Time
Podcast Appearances
It was invigorating.
And I think it represented to me all that one could do in medicine.
Then I learned something interesting.
I started doing research.
Research is a lot of different things and it's governed by a lot of different things.
And the first research project that I did, I can't attribute what came to what, but definitely it was a very positive study and it had a good outcome.
So this was an interesting moment for me because for the first time I looked at this piece of work, I suddenly realized that in a publication like this, you actually had more impact.
There was the one patient you were taking care of, but also the impact on so many other people who would be affected by that research outcome.
Fundamentally, it could change the care of patients, not only in the hospital, in the clinic, in the hospital, in the city, in the region, in the country, and well beyond.
So the concept that research can have such a profound effect was a very different concept than the one I had traditionally thought about.
So that really got me incredibly engaged in thinking about research in the context of patients and thinking about the impact that one could have.
If I look through the various things that I've done in my career, it was getting beyond what I could do as an individual researcher or as leading a group of researchers and thinking, how do you structure things at scale?
so that you can actually change the way research is done?
How do you put together the right infrastructures?
How do you put the right facilities together?
How do you bring together talented researchers so that you could actually create something bigger and future thinking?
What are the resources at the system level that investigators need today?
What are the resources that may be needed for tomorrow?
whether it was looking at some of the fundamental things that had to be put together in data analytics to prepare for artificial intelligence and their impact, whether it was looking at how we structured data with clinical samples to look at the future of genetics.
It was a lot of different things.